神经调控技术与应用
上QQ阅读APP看书,第一时间看更新

参考文献

[1]张建国,王忠诚,张小英,等.丘脑底核电刺激治疗帕金森病.中华神经外科杂志,2002,8(1):4-7.
[2]毕永峰,张建国.脑深部电刺激的作用机制研究进展.中华神经外科杂志,2010,2(8):758-761.
[3]胡小吾,周晓平,王来兴,等.刺激术和毁损术在双侧立体定向手术治疗帕金森病中的比较.中华神经外科杂志,2004,20(4):280-282.
[4]张凯,张建国,吴胜田,等.脑深部电刺激对帕金森病手术的临床应用价值.中华神经外科杂志,2004,20(4):271-274.
[5]张建国,马羽,刘焕光.脑深部电刺激术在中国的发展现状.中国神经精神疾病杂志.2009,27(07):385-387.
[6]王乔树,赵永波,孙伯民,等.丘脑底核深部电刺激对帕金森病患者抑郁及焦虑的影响.临床神经病学杂志,2005,3:170-172.
[7]刘迪,罗晓光.帕金森病泌尿系统症状的研究.医药前沿,2013,16:66-67.
[8]许建平,汪业汉.480例脑立体定向手术的临床总结.立体定向神经外科杂志,1986,1(1):1-4
[9]李跃华,董意如,林友俊,等.脑立体定向治疗震颤麻痹疗效观察.立体定向和功能性神经外科杂志,1993,6(1):38-39
[10]李勇杰,lncono RP.微电极导向的苍白球腹后部切开术治疗帕金森病100例临床分析.中华外科杂志,1998,36(10):603-605
[11]张华,高国栋,张宝国,等.毁损术微刺激的定位作用.中华神经外科杂志,2000,16(2):75-77
[12]张世忠,徐如祥,张旺明,等.微电极导向同期行丘脑及苍白球腹后核毁损治疗帕金森病.中华神经外科杂志,2000,16(2):78-81
[13]张华,高国栋,张宝国,等.丘脑Vim核毁损术中微电极定位技术.中华神经外科杂志,2000,16(6):361-363
[14]凌至培,汪业汉,凌士营,等.慢性丘脑刺激治疗帕金森病.立体定向和功能性神经外科杂志,2000,13(1):27-29
[15]凌至培,汪业汉,牛朝诗,等.丘脑底核高频刺激治疗帕金森病.立体定向和功能性神经外科杂志,2001,14(3):125-128
[16]张宇清,李勇杰,李建宇,等.脑深部电刺激对帕金森病非运动症状的疗效(附102例病例分析).中华神经外科杂志,2009,25(3):245-247
[17]胡小吾,姜秀峰,周晓平,等.运动障碍性疾病立体定向脑深部刺激术和毁损术脑出血原因分析.中华神经外科杂志,2009,25(4):321-323
[18]傅先明.重视帕金森病外科治疗的理念.中华神经外科杂志,2013,29(12):1189-1190
[19]刘蒋,魏祥品,傅先明,等.帕金森病丘脑腹中间核毁损术靶点行定位及调整.中华神经外科杂志,2013,29(12):1204-1207
[20]赵长地,苗兴路,薛健.立体定向脑内核团毁损及深部电刺激术治疗帕金森病54例临床分析.立体定向和功能性神经外科杂志,2013,26(5):325-327
[21]干静,谢晶,Thobois Stéphane,等.帕金森病丘脑底核深部电刺激术后注意事项和并发症.中国神经精神疾病杂志,2007,01:65-67.
[22]马羽,张建国,冯涛.丘脑底核脑深部电刺激对帕金森病术后药物治疗的影响(附40例分析).中国微侵袭神经外科杂志,2006,11(3):102-104.
[23]钱浩,刘金龙,符小丽,等.双侧丘脑底核脑深部电刺激治疗中晚期帕金森病疗效(术后2年随访).中国神经精神疾病杂志,2013,39(5):284-290.
[24]安子薇,李建民,吴庆文,等.帕金森病康复治疗研究新进展.中国煤炭工业医学杂志,2013,16(5):851-853.
[25]朱小霞,陈曦.帕金森病言语障碍的评定及康复治疗研究进展.中国康复医学杂志,2013,28(4):377-380.
[26]Benabid AL,Chabardes S,Mitrofanis J,et al.Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol,2009,8(1):67-81.
[27]Dorsey ER,Constantinescu R,Thompson JP,et al.Projected number of people with Parkinson disease in the most populous nations,2005 through 2030.Neurology,2007,68(5):384-386.
[28]Ferreira JJ,Katzenschlager R,Bloem BR,et al. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol,2013,20(1):5-15.
[29]Okun MS,Gallo BV,Mandybur G,et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease:an open-label randomised controlled trial. Lancet Neurol,2012,11(2):140-149.
[30]Odekerken VJ,van Laar T,Staal MJ,et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study):a randomised controlled trial. Lancet Neurol,2013,12(1):37-44.
[31]Schupbach WM,Rau J,Knudsen K,et al. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med,2013,368(7):610-622.
[32]Macleod AD,Taylor KS,Counsell CE. Mortality in Parkinson's disease:a systematic review and metaanalysis. Mov Disord,2014,29(13):1615-1622.
[33]Deuschl G,Schüpbach M,Knudsen K,et al. Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease:concept and standards of the EARLYSTIM-study. Parkinsonism Relat Disord,2013,19(1):56-61.
[34]Deuschl G,Agid Y. Subthalamic neurostimulation for Parkinson's disease with early fluctuations:balancing the risks and benefits. Lancet Neurol,2013,12(10):1025-1034.
[35]Castrioto A,Lozano AM,Poon YY,et al. Ten-Year Outcome of Subthalamic Stimulation in Parkinson Disease Ten-year outcome. Arch Neurol,2011,68(12):1550-1556.
[36]Deuschl G,Agid Y. Subthalamic neurostimulation for Parkinson's disease with early fluctuations:balancing the risks and benefits. Lancet Neurol,2013,12(10):1025-1034
[37]Deuschl G,Paschen S,Witt K. Clinical outcome of deep brain stimulation for Parkinson's disease. Handb Clin Neurol,2013,116:107-128.
[38]Deuschl G,Schade-Brittinger C,Agid Y,EARLYSTIM Study Group. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med,2013,368(21):2038.
[39]Fasano A,Aquino CC,Krauss JK,et al. Axial disability and deep brain stimulation in patients with Parkinson disease. Nat Rev Neurol,2015,11(2):98-110.
[40]Fasano A,Romito LM,Daniele A,et al. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain,2010,133(9):2664-2676.
[41]Fasano A,Herzog J,Seifert E,et al. Modulation of gait coordination by subthalamic stimulation improves freezing of gait. Mov Disord,2011,26(5):844-851.
[42]Follett KA,Weaver FM,Stern M,et al. Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease. N Engl J Med,2010,362(22):2077-2091.
[43]Hariz M. Early surgery for Parkinson's disease? Maybe,but not just yet. Lancet Neurol,2013,12(10):938-939.
[44]Janssen ML,Duits AA,Tourai AM,et al. Subthalamic Nucleus High-Frequency Stimulation for Advanced Parkinson's Disease:Motor and Neuropsychological Outcome after 10 Years. StereotactFunctNeurosurg,2014,92(6):381-387.
[45]Kalia SK,Lozano AM. Neurostimulation in PD—benefit of early surgery revealed Nat Rev Neurol,2013,9(5):244-245.
[46]Katz M,Luciano MS,Carlson K,et al. Differential Effects of Deep Brain Stimulation Target on Motor Subtypes in Parkinson's Disease Ann Neurol,2015,77(4):710-719.
[47]Keller DL. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med,2013,368(21):2037-2038.
[48]Krack P,Hariz MI. Deep brain stimulation in Parkinson's disease:reconciliation of evidence-based medicine with clinical practice Lancet Neurol,2013,12(1):25-26.
[49]Liu Y,Li W,Tan C,et al. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease. J Neurosurg,2014,121(3):709-718.
[50]Merola A,Zibetti M,Angrisano S,et al. Parkinson's disease progression at 30 years:a study of subthalamic deep brainstimulated patients. Brain,2011,134(7):2074-2084.
[51]Movement Disorder Group,Chan AY,Yeung JH,et al. Subthalamic nucleus deep brain stimulation for Parkinson's disease:evidence for effectiveness and limitations from 12 years' experience. Hong Kong Med J,2014,20(6):474-480.
[52]Ngoga D1,Mitchell R,Kausar J,et al.Deep brain stimulation improves survival in severe Parkinson's disease.J. Neurol. Neurosurg Psychiatry,2014,85(1):17-22.
[53]Odekerken VJ,van Laar T,Staal MJ,et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study):a randomised controlled trial Lancet Neurol,2013,12(1):37-44.
[54]Paek SH,Yun JY,Song SW,et al. The clinical impact of precise electrode positioning in STN-DBS on three-year outcomes. J Neurol Sci,2013,327(1-2):25-31.
[55]Pötter-Nerger M,Volkmann J. Deep brain stimulation for gait and postural symptoms in Parkinson's disease Mov Disord,2013,28(11):1609-1615.
[56]Rocchi L,Carlson-Kuhta P,Chiari L,et al. Effects of deep brain stimulation in the subthalamic nucleus or globus pallidus internus on step initiation in in Parkinson disease:laboratory investigation. J Neurosurg,2012,117(6):1141-1149.
[57]Schuepbach WM,Rau J,Knudsen K,et al. EARLYSTIM Study Group:Neurostimulation for Parkinson's Disease with Early Motor Complications. N Engl J Med,2013,368(7):610-622.
[58]St George RJ,Carlson-Kuhta P,Burchiel KJ,et al. The effects of subthalamic and pallidal deep brain stimulation on postural responses in patients with Parkinson disease.J Neurosurg,2012,116(6):1347-1356.
[59]Tanner CM. A second honeymoon for Parkinson's disease? N Engl J Med,2013,368(7):675-676.
[60]Tsai ST,Hung HY,Hsieh TC,et al. Long-term outcome of young onset Parkinson's disease after subthalamic stimulation—a cross-sectional study. Clin Neurol Neurosurg,2013,115(10):2082-2087.
[61]Weaver FM,Follett KA,Stern M,et al. Randomized trial of deep brain stimulation for Parkinson disease:thirtysix-month outcomes. Neurology,2012,79(1):55-65.
[62]Williams A,Gill S,Varma T,et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease(PD SURG trial):a randomised,open-label trial. Lancet Neurol,2010,(96):581-591.
[63]Xie T,Kang UJ,Warnke P. Effect of stimulation frequency on immediate freezing of gait in newly activated STN-DBS in Parkinson's disease. J Neurol Neurosurg Psychiatry,2012,83(10):1015-1017.
[64]Zhu XL,Chan DT,Lau CK,et al. Cost-effectiveness of subthalmic nucleus deep brain stimulation for treatment of advanced Parkinson's disease in Hong Kong:a prospective study. World Neurosurg,2014,82(6):987-993.
[65]Amara AW,Standaert DG,Guthrie S,et al. Unilateral subthalamic nucleus deep brain stimulation improves sleep quality in Parkinson's disease. Parkinsonism Relat Disord,2012,18(1):63-68.
[66]Alatriste-Booth V,Rodriguez-Violante M,Camacho-Ordonez A,et al. Prevalence and correlates of sleep disorders in Parkinson's disease:a polysomnographic study. ArqNeuropsiquiatr,2015,73(3):241-245.
[67]Amara AW,Watts RL,Walker HC. The effects of deep brain stimulation on sleep in Parkinson's disease. Ther Adv Neurol Disord,2011,4(1):15-24.
[68]Peppe A,Pierantozzi M,Baiamonte V,et al. Deep brain stimulation of pedunculopontine tegmental nucleus:role in sleep modulation in advanced Parkinson disease patients:one-year follow-up. Sleep,2012,35(12):1637-1642.
[69]Broen M,Duits A,Visser-Vandewalle V,et al. Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation:a review. Parkinsonism Relat Disord,2011,17(6):413-417.
[70]Smith H,Gee L,Kumar V,et al. Deep brain stimulation significantly decreases disability from low back pain in patients with advanced Parkinson's disease.StereotactFunctNeurosurg,2015,93(3):206-211.
[71]Gokbayrak NS,Piryatinsky I,Gavett RA,et al.Mixed effects of deep brain stimulation on depressive symptomatology in Parkinson's disease:a review of randomized clinical trials. Front Neurol,2014,5:154.
[72]Aviles-Olmos I,Foltynie T,Panicker J,et al. Urinary incontinence following deep brain stimulation of the pedunculopontine nucleus. Acta Neurochir (Wien),2011,153(12):2357-2360.
[73]Li F,Harmer P,Fitzgerald K,et al. Tai chi and postural stability in patients with Parkinson's disease. N Eng J Med,2012,366(6):511-519.
[74]Corcos DM,Robichaud JA,David FJ,et al. A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease. Movement Disorders,2013,28(9):1230-1240.
[75]Miocinovic S,Somayajula S,Chitnis S,Vitek JL. History,applications,and mechanisms of deep brain stimulation.JAMA Neurol,2013,70(2):163-171.
[76]Da Cunha C,Boschen SL,Gómez-A A,et al. Toward sophisticated basal ganglia neuromodulation:Review on basal ganglia deep brain stimulation. Neurosci Biobehav Rev,2015,58:186-210.
[77]Agnesi F,Johnson MD,Vitek JL. Deep brain stimulation:how does it work? Handb Clin Neurol,2013,116:39-54.
[78]Min HK,Ross EK,Lee KH,et al. Subthalamic nucleus deep brain stimulation induces motor network BOLD activation:use of a high precision MRI guided stereotactic system for nonhuman primates. Brain Stimul,2014,7(4):603-607.
[79]Santaniello S,McCarthy MM,Montgomery EB Jr,et al.Therapeutic mechanisms of high-frequency stimulation in Parkinson's disease and neural restoration via loopbased reinforcement. Proc Natl Acad Sci USA,2015,112(6):E586-595.
[80]Stein E1,Bar-Gad I. β oscillations in the cortico-basal ganglia loop during parkinsonism. Exp Neurol,2013,245:52-59.
[81]Eusebio A,Thevathasan W,Doyle Gaynor L,et al.Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients. J Neurol Neurosurg Psychiatry,2011,82(5):569-573.
[82]Lyons MK. Deep brain stimulation:current and future clinical applications. Mayo Clin Proc,2011,86(7):662-672.
[83]Bickel S,Alvarez L,Macias R,et al. Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson's disease. Parkinsonism and Related Disorders,2010,16:535-539.
[84]Bour Lo J,Contarino MF,Foncke EMJ,et al. Long-term experience with intraoperative microrecording during DBS neurosurgery in STN and GPi Acta Neurochir,2010,152:2069-2077.
[85]Castrioto A,Lozano AM,Poon Yu-Yan,et al. Ten-Year Outcome of Subthalamic Stimulation in Parkinson Disease. Arch Neurol,2011,68 (12):1550-1556.
[86]Bahgat D,Magill ST,Berk C,et al. Thalamotomy as a Treatment Option for Tremor after Ineffective Deep Brain Stimulation. StereotactFunctNeurosurg,2013,91:18-23.
[87]Jourdain VA,Gastón Schechtmann G. Health Economics and Surgical Treatment for Parkinson's Disease in a World Perspective:Results from an International Survey.StereotactFunctNeurosurg,2014,92:71-79.
[88]Sapir S,Ramig LO,Fox CM. Intensive voice treatment in Parkinson's disease:Lee Silverman Voice Treatment.Expert Rev Neurother,2011,11(6):815-830.
[89]Cannito MP,Suiter DM,Beverly D,et al. Sentence intelligibility before and after voice treatment in speakers with idiopathic Parkinson's disease. J Voice,2012,26(2):214-219.
[90]Bentivoglio AR,Fasano A,Piano C,et al. Unilateral extradural motor cortex stimulation is safe and improves Parkinson disease at 1 year. Neurosurgery,2012,71(4):815-825.